Publications
- Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting2008 | First Faculty of Medicine
- HPMA-based doxorubicin conjugate containing human intravenous immunoglobulins shows anticancer effect and protection of immunityPublication without faculty affiliation
- HPMA copolymers with hydrazone-attached doxorubicin are efficient in the treatment of mouse T cell lymphoma EL4Publication without faculty affiliation
- Immunostimulatory/immunoprotective effects of macromolecular anticancer therapeuticsPublication without faculty affiliation
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting2008 | First Faculty of Medicine
- Overcoming Immunoescape Mechanisms of BCL1 Leukemia and Induction of CD8(+) T-Cell-Mediated BCL1-Specific Resistance in Mice Cured by Targeted Polymer-Bound Doxorubicin2008 | First Faculty of Medicine
- Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice2007 | First Faculty of Medicine
- Properties of HMPA copolymer - doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification2006 | First Faculty of Medicine
- Properties of HMPA copolymer - doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification2006 | Faculty of Physical Education and Sport
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | First Faculty of Medicine
Loading network view...